Outset Medical, Inc.
$3.26+0.10 (+3.16%)
Prev Close
$3.16
Open
$3.21
High
$3.47
Low
$3.19
Volume
157.1K
Market Cap
$59.0M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Outset Medical, Inc. (OM) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $292.1K. The most recent insider transaction was by Brottem John L. (officer: General Counsel), who sold $9.5K worth of shares on Feb 19, 2026. Outset Medical, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $59.0M.
Buys (12M)
0
$0.00
Sells (12M)
23
$292.1K
Net Activity
Net Seller
$292.1K
Active Insiders
5
last 12 mo
OM Price Chart
OM Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026↗ | Brottem John L. | officer: General Counsel | Sell | 2,842 | $3.35 | $9.5K | 32,935 |
| Feb 19, 2026↗ | Nash Marc | officer: EVP Operations R&D & Service | Sell | 1,817 | $3.35 | $6.1K | 39,988 |
| Feb 19, 2026↗ | Trigg Leslie | director, officer: Chair and CEO | Sell | 3,361 | $3.35 | $11.3K | 102,342 |
| Feb 17, 2026↗ | Brottem John L. | General Counsel | Sell | 2,842 | $3.35 | $9.5K | 0 |
| Feb 17, 2026↗ | Nash Marc | EVP Operations R&D & Service | Sell | 1,817 | $3.35 | $6.1K | 0 |
| Feb 17, 2026↗ | Trigg Leslie | Chair and CEO | Sell | 3,361 | $3.35 | $11.3K | 0 |
| Jan 21, 2026↗ | Brottem John L. | officer: General Counsel | Sell | 10,494 | $5.11 | $53.6K | 36,957 |
| Jan 21, 2026↗ | Nash Marc | officer: EVP Operations R&D & Service | Sell | 6,355 | $5.10 | $32.4K | 42,785 |
| Jan 21, 2026↗ | Trigg Leslie | director, officer: Chair and CEO | Sell | 13,914 | $5.11 | $71.1K | 107,823 |
| Jan 8, 2026↗ | Brottem John L. | officer: General Counsel | Sell | 224 | $4.27 | $956.48 | 46,271 |
| Jan 8, 2026↗ | Nash Marc | officer: EVP Operations R&D & Service | Sell | 108 | $4.27 | $461.16 | 48,160 |
| Jan 8, 2026↗ | Trigg Leslie | director, officer: Chair and CEO | Sell | 1,795 | $4.27 | $7.7K | 119,617 |
| Dec 2, 2025↗ | Drexler Karen | Director | Sell | 1,548 | $4.37 | $6.8K | 10,650 |
| Nov 18, 2025↗ | Brottem John L. | General Counsel | Sell | 388 | $4.60 | $1.8K | 46,495 |
| Nov 18, 2025↗ | Nash Marc | EVP Operations R&D & Service | Sell | 247 | $4.60 | $1.1K | 48,268 |
| Nov 18, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 916 | $4.60 | $4.2K | 121,412 |
| Aug 18, 2025↗ | Brottem John L. | General Counsel | Sell | 383 | $12.88 | $4.9K | 46,883 |
| Aug 18, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 243 | $12.88 | $3.1K | 42,898 |
| Aug 18, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 904 | $12.88 | $11.6K | 122,328 |
| May 16, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 584 | $17.81 | $10.4K | 16,096 |
| May 16, 2025↗ | Brottem John L. | General Counsel | Sell | 396 | $17.82 | $7.1K | 11,273 |
| May 16, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 252 | $17.82 | $4.5K | 13,465 |
| May 16, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 935 | $17.80 | $16.6K | 58,129 |
| Feb 19, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 8,659 | $0.90 | $7.8K | 250,210 |
| Feb 19, 2025↗ | Brottem John L. | General Counsel | Sell | 6,145 | $0.90 | $5.5K | 175,043 |
| Feb 19, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 4,204 | $0.90 | $3.8K | 200,764 |
| Feb 19, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 14,611 | $0.90 | $13.1K | 880,969 |
| Jan 22, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 34,288 | $0.80 | $27.4K | 292,250 |
| Jan 22, 2025↗ | Brottem John L. | General Counsel | Sell | 32,930 | $0.80 | $26.3K | 213,341 |
| Jan 22, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 23,221 | $0.80 | $18.6K | 227,833 |
| Jan 22, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 65,236 | $0.80 | $52.2K | 956,413 |
| Jan 13, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 29,031 | $0.81 | $23.5K | 279,901 |
| Jan 13, 2025↗ | Brottem John L. | General Counsel | Sell | 20,492 | $0.81 | $16.6K | 205,028 |
| Jan 13, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 15,011 | $0.81 | $12.2K | 222,291 |
| Jan 13, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 33,227 | $0.81 | $26.9K | 861,397 |
| Jan 7, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 1,835 | $1.29 | $2.4K | 308,932 |
| Jan 7, 2025↗ | Brottem John L. | General Counsel | Sell | 1,572 | $1.29 | $2.0K | 225,520 |
| Jan 7, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 720 | $1.29 | $928.80 | 237,302 |
| Jan 7, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 10,227 | $1.29 | $13.2K | 894,624 |
| Nov 18, 2024↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 4,221 | $0.80 | $3.4K | 310,767 |
| Nov 18, 2024↗ | Brottem John L. | General Counsel | Sell | 3,203 | $0.80 | $2.6K | 227,092 |
| Nov 18, 2024↗ | Nash Marc | SVP Operations and R&D | Sell | 1,375 | $0.80 | $1.1K | 238,022 |
| Nov 18, 2024↗ | Trigg Leslie | Chair and CEO | Sell | 5,645 | $0.80 | $4.5K | 904,851 |
| Aug 15, 2024↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 3,971 | $0.84 | $3.3K | 314,988 |
| Aug 15, 2024↗ | Brottem John L. | General Counsel | Sell | 3,011 | $0.84 | $2.5K | 230,295 |
| Aug 15, 2024↗ | Nash Marc | SVP Operations and R&D | Sell | 1,293 | $0.84 | $1.1K | 239,397 |
| Aug 15, 2024↗ | Trigg Leslie | Chair and CEO | Sell | 5,308 | $0.84 | $4.5K | 910,496 |
| Jul 24, 2024↗ | Nash Marc | SVP Operations and R&D | Sell | 723 | $4.02 | $2.9K | 240,690 |
| Jun 14, 2024↗ | Brottem John L. | General Counsel | Sell | 10,569 | $4.78 | $50.5K | 233,306 |
| Jun 3, 2024↗ | GROSSMAN D KEITH | Director | Sell | 38,117 | $3.78 | $144.2K | 74,035 |
Showing 1–50 of 239
1 / 5
OM Insider Buying Activity
The following table shows recent insider purchases of Outset Medical, Inc. (OM) stock reported via SEC Form 4 filings.
No insider buying activity found for OM in the last 12 months.
OM Insider Selling Activity
The following table shows recent insider sales of Outset Medical, Inc. (OM) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026↗ | Brottem John L. | officer: General Counsel | Sell | 2,842 | $3.35 | $9.5K | 32,935 |
| Feb 19, 2026↗ | Nash Marc | officer: EVP Operations R&D & Service | Sell | 1,817 | $3.35 | $6.1K | 39,988 |
| Feb 19, 2026↗ | Trigg Leslie | director, officer: Chair and CEO | Sell | 3,361 | $3.35 | $11.3K | 102,342 |
| Feb 17, 2026↗ | Brottem John L. | General Counsel | Sell | 2,842 | $3.35 | $9.5K | 0 |
| Feb 17, 2026↗ | Nash Marc | EVP Operations R&D & Service | Sell | 1,817 | $3.35 | $6.1K | 0 |
| Feb 17, 2026↗ | Trigg Leslie | Chair and CEO | Sell | 3,361 | $3.35 | $11.3K | 0 |
| Jan 21, 2026↗ | Brottem John L. | officer: General Counsel | Sell | 10,494 | $5.11 | $53.6K | 36,957 |
| Jan 21, 2026↗ | Nash Marc | officer: EVP Operations R&D & Service | Sell | 6,355 | $5.10 | $32.4K | 42,785 |
| Jan 21, 2026↗ | Trigg Leslie | director, officer: Chair and CEO | Sell | 13,914 | $5.11 | $71.1K | 107,823 |
| Jan 8, 2026↗ | Brottem John L. | officer: General Counsel | Sell | 224 | $4.27 | $956.48 | 46,271 |
| Jan 8, 2026↗ | Nash Marc | officer: EVP Operations R&D & Service | Sell | 108 | $4.27 | $461.16 | 48,160 |
| Jan 8, 2026↗ | Trigg Leslie | director, officer: Chair and CEO | Sell | 1,795 | $4.27 | $7.7K | 119,617 |
| Dec 2, 2025↗ | Drexler Karen | Director | Sell | 1,548 | $4.37 | $6.8K | 10,650 |
| Nov 18, 2025↗ | Brottem John L. | General Counsel | Sell | 388 | $4.60 | $1.8K | 46,495 |
| Nov 18, 2025↗ | Nash Marc | EVP Operations R&D & Service | Sell | 247 | $4.60 | $1.1K | 48,268 |
| Nov 18, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 916 | $4.60 | $4.2K | 121,412 |
| Aug 18, 2025↗ | Brottem John L. | General Counsel | Sell | 383 | $12.88 | $4.9K | 46,883 |
| Aug 18, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 243 | $12.88 | $3.1K | 42,898 |
| Aug 18, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 904 | $12.88 | $11.6K | 122,328 |
| May 16, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 584 | $17.81 | $10.4K | 16,096 |
| May 16, 2025↗ | Brottem John L. | General Counsel | Sell | 396 | $17.82 | $7.1K | 11,273 |
| May 16, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 252 | $17.82 | $4.5K | 13,465 |
| May 16, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 935 | $17.80 | $16.6K | 58,129 |
| Feb 19, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 8,659 | $0.90 | $7.8K | 250,210 |
| Feb 19, 2025↗ | Brottem John L. | General Counsel | Sell | 6,145 | $0.90 | $5.5K | 175,043 |
| Feb 19, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 4,204 | $0.90 | $3.8K | 200,764 |
| Feb 19, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 14,611 | $0.90 | $13.1K | 880,969 |
| Jan 22, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 34,288 | $0.80 | $27.4K | 292,250 |
| Jan 22, 2025↗ | Brottem John L. | General Counsel | Sell | 32,930 | $0.80 | $26.3K | 213,341 |
| Jan 22, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 23,221 | $0.80 | $18.6K | 227,833 |
| Jan 22, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 65,236 | $0.80 | $52.2K | 956,413 |
| Jan 13, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 29,031 | $0.81 | $23.5K | 279,901 |
| Jan 13, 2025↗ | Brottem John L. | General Counsel | Sell | 20,492 | $0.81 | $16.6K | 205,028 |
| Jan 13, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 15,011 | $0.81 | $12.2K | 222,291 |
| Jan 13, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 33,227 | $0.81 | $26.9K | 861,397 |
| Jan 7, 2025↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 1,835 | $1.29 | $2.4K | 308,932 |
| Jan 7, 2025↗ | Brottem John L. | General Counsel | Sell | 1,572 | $1.29 | $2.0K | 225,520 |
| Jan 7, 2025↗ | Nash Marc | SVP Operations and R&D | Sell | 720 | $1.29 | $928.80 | 237,302 |
| Jan 7, 2025↗ | Trigg Leslie | Chair and CEO | Sell | 10,227 | $1.29 | $13.2K | 894,624 |
| Nov 18, 2024↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 4,221 | $0.80 | $3.4K | 310,767 |
| Nov 18, 2024↗ | Brottem John L. | General Counsel | Sell | 3,203 | $0.80 | $2.6K | 227,092 |
| Nov 18, 2024↗ | Nash Marc | SVP Operations and R&D | Sell | 1,375 | $0.80 | $1.1K | 238,022 |
| Nov 18, 2024↗ | Trigg Leslie | Chair and CEO | Sell | 5,645 | $0.80 | $4.5K | 904,851 |
| Aug 15, 2024↗ | Ahmed Nabeel | Chief Financial Officer | Sell | 3,971 | $0.84 | $3.3K | 314,988 |
| Aug 15, 2024↗ | Brottem John L. | General Counsel | Sell | 3,011 | $0.84 | $2.5K | 230,295 |
| Aug 15, 2024↗ | Nash Marc | SVP Operations and R&D | Sell | 1,293 | $0.84 | $1.1K | 239,397 |
| Aug 15, 2024↗ | Trigg Leslie | Chair and CEO | Sell | 5,308 | $0.84 | $4.5K | 910,496 |
| Jul 24, 2024↗ | Nash Marc | SVP Operations and R&D | Sell | 723 | $4.02 | $2.9K | 240,690 |
| Jun 14, 2024↗ | Brottem John L. | General Counsel | Sell | 10,569 | $4.78 | $50.5K | 233,306 |
| Jun 3, 2024↗ | GROSSMAN D KEITH | Director | Sell | 38,117 | $3.78 | $144.2K | 74,035 |
OM Insiders
Similar Stocks to OM
ABT
Abbott Laboratories
$108.01-0.12%
$187.91B
SYK
Stryker Corporation
$336.96-0.07%
$129.05B
MDT
Medtronic plc
$87.06-0.37%
$112.19B
BSX
Boston Scientific Corporation
$68.91+0.51%
$101.72B
EW
Edwards Lifesciences Corporation
$81.76-3.37%
$49.14B
BRKRP
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
$273.67-3.21%
$47.35B
DXCM
DexCom, Inc.
$64.51-1.15%
$25.45B
ZBH
Zimmer Biomet Holdings, Inc.
$93.20+0.77%
$18.47B